Company Overview of Inserm Transfert Initiative
Inserm Transfert Initiative is a venture capital firm specializing in incubation, pre-seed, seed, start-up, early and growth stages. It mainly targets investments in spin-offs from top tier academic research. The firm focuses on investments in the health, biotechnology, biomedicine, and life sciences sectors. It aims to invest in companies with economic activities in France. The firm invests between €0.1 million ($0.12 million) and €0.3 million ($0.36 million) in the healthcare sector, and an average of and €2 million ($2 million) in the life sciences sector. It seeks to invest between €1 million ($1.19 million) and €2 million ($2 million), made in one or multiple tranches. The firm may also...
7 rue Watt
Founded in 2005
Key Executives for Inserm Transfert Initiative
Chief Executive Officer, President, Managing Partner, and Member of Advisory Committee
Compensation as of Fiscal Year 2014.
Inserm Transfert Initiative Key Developments
Inserm Transfert Initiative Presents at BIO-Europe Spring 2015, Mar-09-2015
Jan 29 15
Inserm Transfert Initiative Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.
Inserm Transfert Initiative Presents at BioEquity Europe 2014, May-21-2014 02:15 PM
Apr 29 14
Inserm Transfert Initiative Presents at BioEquity Europe 2014, May-21-2014 02:15 PM. Venue: Hilton Amsterdam Hotel, Amsterdam, Netherlands. Speakers: Matthieu Coutet, Chief Executive Officer.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries